Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Iuliani

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cancer Diagnosis & Prognosis|July 2, 2026
Impact of Local Treatment of the Primary Tumor on Overall Survival in <i>De Novo</i> Metastatic Breast Cancer: A Systematic Review and Meta-analysisLuisana Sisca, Mariam Grazia Polito, Michele Iuliani, et al.
The Lancet. Oncology|May 3, 2019
Early use of abiraterone and radium-223 in metastatic prostate cancerMaria Concetta Cursano, Daniele Santini, Michele Iuliani, et al.
Expert Opinion on Emerging Drugs|June 1, 2011
New targets, new drugs for metastatic bone pain: a new philosophyFrancesco Pantano, Alice Zoccoli, Michele Iuliani, et al.
G3 (Bethesda, Md.)|November 29, 2015
SAGA DUB-Ubp8 Deubiquitylates Centromeric Histone Variant Cse4Claudia Canzonetta, Stefano Vernarecci, Michele Iuliani, et al.
Biomolecules|March 28, 2026
Circulating Tumor Cells: Isolation, Preclinical Models, and Clinical Applications for Personalized Cancer TherapyLuisana Sisca, Mariam Grazia Polito, Michele Iuliani, et al.
Frontiers in Oncology|July 2, 2026
Artificial intelligence-enabled liquid biopsy in cancer: a systematic review and meta- analysis of diagnostic performance and biological implicationsLuisana Sisca, Mariam Grazia Polito, Emy Sisca, et al.
Biomedicines|September 23, 2022
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell ProliferationMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Frontiers in Oncology|December 30, 2021
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent MechanismsGiulia Ribelli, Sonia Simonetti, Michele Iuliani, et al.
Journal for Immunotherapy of Cancer|September 14, 2022
Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinomaSonia Simonetti, Michele Iuliani, Marco Stellato, et al.
Molecules (Basel, Switzerland)|July 15, 2014
MicroRNAs and bone metastasis: a new challengeMartine Croset, Daniele Santini, Michele Iuliani, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cancer Diagnosis & Prognosis|July 2, 2026
Impact of Local Treatment of the Primary Tumor on Overall Survival in <i>De Novo</i> Metastatic Breast Cancer: A Systematic Review and Meta-analysisLuisana Sisca, Mariam Grazia Polito, Michele Iuliani, et al.
The Lancet. Oncology|May 3, 2019
Early use of abiraterone and radium-223 in metastatic prostate cancerMaria Concetta Cursano, Daniele Santini, Michele Iuliani, et al.
Expert Opinion on Emerging Drugs|June 1, 2011
New targets, new drugs for metastatic bone pain: a new philosophyFrancesco Pantano, Alice Zoccoli, Michele Iuliani, et al.
G3 (Bethesda, Md.)|November 29, 2015
SAGA DUB-Ubp8 Deubiquitylates Centromeric Histone Variant Cse4Claudia Canzonetta, Stefano Vernarecci, Michele Iuliani, et al.
Biomolecules|March 28, 2026
Circulating Tumor Cells: Isolation, Preclinical Models, and Clinical Applications for Personalized Cancer TherapyLuisana Sisca, Mariam Grazia Polito, Michele Iuliani, et al.
Frontiers in Oncology|July 2, 2026
Artificial intelligence-enabled liquid biopsy in cancer: a systematic review and meta- analysis of diagnostic performance and biological implicationsLuisana Sisca, Mariam Grazia Polito, Emy Sisca, et al.
Biomedicines|September 23, 2022
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell ProliferationMichele Iuliani, Sonia Simonetti, Giulia Ribelli, et al.
Frontiers in Oncology|December 30, 2021
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent MechanismsGiulia Ribelli, Sonia Simonetti, Michele Iuliani, et al.
Journal for Immunotherapy of Cancer|September 14, 2022
Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinomaSonia Simonetti, Michele Iuliani, Marco Stellato, et al.
Molecules (Basel, Switzerland)|July 15, 2014
MicroRNAs and bone metastasis: a new challengeMartine Croset, Daniele Santini, Michele Iuliani, et al.
Pageof 5